LFSTLifeStance Health Group, Inc.
$12.43+138% 1Y
$12.43
$4.8152 weeks$13.39
LFST in its own filings
Nothing in LFST's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
85
Events found in the filings · across 499 filings · the record starts in 2021
- Hard flags
- none
Hard flags
- Most recent filing
- Sep 11, 2026
Most recent filing · Form 8-K
- Record starts
- Mar 16, 2021
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 5, 2026
- SEC comment-letter activity14 occurrences
- 2023-10-06
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 11, 2026On September 9, 2026, LifeStance Health Group, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) by and among the Company, Barclays Capital Inc. (the “Underwriter”), and the selling stockholders named in Schedule II thereto (the “Selling Stockholders”), relating to the …Other event · Form 8-K
- Aug 6, 2026On August 5, 2026, the Board of Directors of the Company approved a share repurchase program, which authorizes the Company to repurchase up to $100 million of the Company's outstanding shares of common stock (the "Repurchase Program")Earnings release · Form 8-K
- Jul 7, 2026On July 2, 2026, Jeffrey Rhodes notified the LifeStance Health Group, Inc. (the “Company”) board of directors (the “Board”) of his resignation from the Board and all of its committees, effective immediately.Director or officer change · Form 8-K
- May 12, 2026On May 7, 2026, LifeStance Health Group, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) by and among the Company, J.P. Morgan Securities LLC (the “Underwriter”), and the selling stockholders named in Schedule II thereto (the “Selling Stockholders”), relating to the …Other event · Form 8-K
- May 7, 2026VP of Finance & Investor Relations.Earnings release · press release
- Mar 11, 2026On March 10, 2026 (the “Start Date”), LifeStance Health Group, Inc. (“LifeStance” or the “Company”) promoted Lisa Miller, age 52, to serve as the Company’s Chief Operating Officer and Principal Operating Officer.Director or officer change · Form 8-K
- Mar 2, 2026On February 25, 2026, LifeStance Health Group, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) by and among the Company, J.P. Morgan Securities LLC (the “Underwriter”), and the selling stockholders named in Schedule II thereto (the “Selling Stockholders”), relating to the …Other event · Form 8-K
- Feb 25, 2026On February 25, 2026, Kenneth Burdick, Executive Chairman of the Board of Directors of the Company (the “Board”) announced his planned transition to non-executive Chairman of the Board effective March 16, 2026.Earnings release · Form 8-K
- Nov 6, 2025VP of Finance & Investor Relations.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Medical Care Facilities
Ranks #20 of 27 by RyuScore